Want to see HIT full AI Analyst Report?
HIT Stock Chart & Stats
$1.06
$0.00(0.00%)
At close: 4:00 PM EDT
$1.06
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.85 - $4.02
Previous Close$5.45
Volume11.84K
Average Volume (3M)86.29K
Market Cap
$70.80M
Enterprise Value$72.96
Total Cash (Recent Filing)$10.33M
Total Debt (Recent Filing)$121.59K
Price to Earnings (P/E)―
Beta1.43
Next Earnings
Nov 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding53,858,080
10 Day Avg. Volume58,983
30 Day Avg. Volume86,289
Financial Highlights & Ratios
PEG Ratio0.80
Price to Book (P/B)5.19
Price to Sales (P/S)2.66
P/FCF Ratio-1.58K
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$4.00Price Target Upside277.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.06
Revenue Forecast (FY)$46.83M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage and a growing equity base provide durable financial flexibility over the next 2–6 months. This lowers refinancing and solvency risk, lets management fund strategic product and sales investments without immediate liquidity strain, and cushions against near-term cash volatility while pursuing growth.
Strong Revenue Base And ScalabilityA solid 2025 revenue baseline combined with a compact sales footprint implies meaningful operating leverage as distribution scales. Adding modest sales capacity and broker partnerships can expand revenue materially without proportional cost increases, supporting sustainable top-line growth over the medium term.
Product And Tech Momentum With PartnersRapid product releases, AI-driven features and an AWS-focused partner/CTO strengthen the platform moat. Improved architecture and analytics increase broker and carrier stickiness, shorten sales cycles, and lower long-run servicing costs, creating durable competitive advantages in the underpenetrated self-funded market.
Bears Say
Severe Cash Flow DeteriorationExtremely negative TTM operating and free cash flow elevates financing and execution risk over the coming quarters. Persistent cash burn can force additional capital raises or spending cuts, constrain product and sales investments, and reduce runway despite the recent PIPE unless cash generation improves sustainably.
Profitability Deterioration And Higher OpexA material swing to negative EBITDA and sharply higher expense ratios signal deteriorating margin sustainability. Unless revenue scale or efficiency gains offset elevated S&M and G&A, continued margin pressure could persist for multiple quarters, limiting free cash flow recovery and return on invested capital.
Guidance And Revenue-recognition Visibility RiskA large discrepancy between public guidance and an internal recognition estimate creates durable visibility risk. This undermines planning, may cause misaligned resource allocation, and raises the chance of missed expectations over the next 2–6 months, increasing execution risk for the growth plan.
Health In Tech, Inc. Class A News
HIT FAQ
What was Health In Tech, Inc. Class A’s price range in the past 12 months?
Health In Tech, Inc. Class A lowest stock price was $0.85 and its highest was $4.02 in the past 12 months.
What is Health In Tech, Inc. Class A’s market cap?
Health In Tech, Inc. Class A’s market cap is $70.80M.
When is Health In Tech, Inc. Class A’s upcoming earnings report date?
Health In Tech, Inc. Class A’s upcoming earnings report date is Nov 16, 2026 which is in 108 days.
How were Health In Tech, Inc. Class A’s earnings last quarter?
Currently, no data Available
Is Health In Tech, Inc. Class A overvalued?
According to Wall Street analysts Health In Tech, Inc. Class A’s price is currently Undervalued.
Does Health In Tech, Inc. Class A pay dividends?
Health In Tech, Inc. Class A does not currently pay dividends.
What is Health In Tech, Inc. Class A’s EPS estimate?
Health In Tech, Inc. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Health In Tech, Inc. Class A have?
Health In Tech, Inc. Class A has 53,858,080 shares outstanding.
What happened to Health In Tech, Inc. Class A’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Health In Tech, Inc. Class A?
Currently, no hedge funds are holding shares in HIT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Health In Tech, Inc. Class A Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (277.36% Upside)
$4.00 (277.36% Upside)
Blogger Sentiment
Bullish
HIT Sentiment 70%
Sector Average 62%
Sector Average 62%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 3.6%
Last 30 Days ▼ 3.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.36%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
39.86%
Trailing 12-Months
Company Description
Health In Tech, Inc. Class A
Health In Tech, Inc. operates as a cutting-edge insurance technology provider. The company delivers a range of specialized insurance solutions for smaller enterprises, such as value-based pricing strategies, group insurance captives, localized community health plans, and collective association health programs. Additionally, it offers the enhanced "do it yourself" benefit system (eDIYBS), a cloud-based SaaS platform engineered to efficiently generate health insurance quotes for small to medium-sized businesses. Health In Tech further supports healthcare administration with its "health intelligence" (HI) card, which streamlines the management of medical records and claims. Complementing this is the HI performance network, an extensive series of medical facilities that utilize Medicare-based reimbursement pricing. This organization was established in 2014 and its principal offices are located in Stuart, Florida.
HIT Company Deck
HIT Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call highlighted strong product and technology progress (new platform features, PPPV disclosure, 100+ pre-configured plans, AWS partnership), a meaningful market opportunity, and modest capital raised to fund growth. However, near-term financials show a clear trade-off: deliberate, sizable investments have pushed adjusted EBITDA and net income into negative territory, operating expense ratios rose materially, and there is a notable inconsistency between management's reiterated FY guidance ($45M–$50M) and the CFO's stated internal recognition estimate ($31.7M), creating short-term visibility risk. Overall, the call balances tangible product and pipeline momentum with short-term profitability and guidance uncertainties.View all HIT earnings summariesHIT Stock 12 Month Forecast
Average Price Target
$4.00
▲(277.36% Upside)
Technical Analysis
Ownership Overview
61.86% Insiders
1.31% Mutual Funds
0.02% Other Institutional Investors
35.63% Public Companies and
Individual Investors